Blacksmith Brands acquires five McNeil OTC brands, inks deal with The Emerson Group
NEW YORK Blacksmith Brands on Friday announced that it had completed its acquisition of five over-the-counter consumer brands from McNeil, including Efferdent denture cleaner, Effergrip denture adhesive cream, Luden’s throat drops, Pediacare children’s cough-and-cold medicine and Gentle Vapors waterless vaporizer, and Nasalcrom, a nasal allergy relief spray.
Concurrent with this acquisition, Blacksmith Brands has announced a key business and equity partnership with The Emerson Group. The Emerson Group, a sales and marketing company located in Wayne, Pa., will provide sales and sales management services.
“We are pleased and proud to have The Emerson Group as our partner not only in the operation of our business, but as an equity partner in our new company,” stated Peter Mann, Blacksmith CEO. “We believe that the Emerson Group will be a key catalyst in our plans to grow Blacksmith Brands into a major consumer products company.
Donnenfeld joins Advanced Vision Research
WOBURN, Mass. Advanced Vision Research named Eric Donnenfeld to the post of chief medical officer.
“Donnenfeld is one of the pre-eminent ophthalmologists practicing today with a broad scope of experience and knowledge,” stated Leigh Reynolds, Advanced Vision COO. “He is a key thought leader who will play a critical role for Advanced Vision Research as we move forward with new product research and development,” he said.
Donnenfeld has been a leader in ophthalmology for more than 20 years, the eye-care company stated. He is on the editorial board of nine medical journals, and is one of the authors of the American Academy of Ophthalmology’s Refractive Surgery Basic Science Book. Donnenfeld graduated with honors at the top of his class at Dartmouth Medical School. He was chief resident at Manhattan Eye Ear and Throat Hospital and he completed his Cornea and Refractive Fellowship at Wills Eye Hospital in Philadelphia.
Bodybuilding.com heeds FDA recall of dietary supplements
BOISE, Idaho Bodybuilding.com on Tuesday announced that it is conducting a voluntary nationwide and international recall of all lots and expiration dates of 65 dietary supplement products that were sold through the company’s Web site, www.bodybuilding.com, after learning from the Food and Drug Administration that the recalled products may contain steroids.
Specifically, the FDA has advised Bodybuilding.com of the agency’s concern that the recalled products may contain the following ingredients that are currently classified, or the FDA believes should be classified, as steroids: “Superdrol,” “Madol,” “Tren,” “Androstenedione,” and/or “Turinabol.”
Bodybuilding.com claimed it had not had an opportunity to independently confirm the FDA’s concerns that the products in fact contain these ingredients, but was initiating the recall in “an abundance of caution.”